NVIDIA: Healthcare

SEPTEMBER 23, 2024

“The Sanger Institute handles hundreds of thousands of somatic samples annually,” said Jingwei Wang, principal software developer for CASM at the Wellcome Sanger Institute. Reducing Runtime and Energy Consumption The Sanger Institute develops high-throughput models of cancer samples for genome-wide functional screens and drug testing.

Sample 136

Sample Collaboration Operation 136

NVIDIA: Healthcare

SEPTEMBER 19, 2024

In collaboration with NVIDIA, we will bring accelerated computing, generative AI and Omniverse integration across the Siemens Xcelerator portfolio.” Its cancer program sequences and analyzes tens of thousands of cancer samples. Siemens and NVIDIA executives will talk about their sustainability efforts in a Sept.

Sample 143

Sample Collaboration Operation 143

IU School of Medicine

MARCH 11, 2024

After earning a second Walther grant of $200,000, the group has been conducting experiments to test their theory using much larger sample sizes across the multiple renal tumor subtypes.

Collaboration 52

Collaboration Sample Operating Room Communication 52

NVIDIA: Healthcare

SEPTEMBER 27, 2023

Medical-device company Invenio Imaging is developing technology that enables surgeons to evaluate tissue biopsies in the operating room, immediately after samples are collected — providing in just three minutes AI-accelerated insights that would otherwise take weeks to obtain from a pathology lab. alone, lung nodules are found in over 1.5

Operating Room 52

Operating Room Sample Operation Collaboration 52

IU School of Medicine

MARCH 11, 2024

In the more than 5,000 samples of normal breast tissue that have been donated to the Susan G. As a result of this collaborative effort, 30 percent of the BRE12-158 study participants were Black—a number that is significantly higher than the national average of 5 percent participation from Black patients in clinical trials, Bales noted.

Collaboration 98

Collaboration Sample 98

IU School of Medicine

MARCH 11, 2024

The Whac-a-Mole trial was undergirded by years of research in Radovich’s lab, beginning by comparing samples of healthy breast tissue from the Susan G. Komen Tissue Bank at the IU Simon Comprehensive Cancer Center with tissue samples from breast cancer patients with TNBC.

Sample 98

Sample Collaboration Communication Hospital 98

IU School of Medicine

OCTOBER 18, 2024

In the more than 5,000 samples of normal breast tissue that have been donated to the Susan G. As a result of this collaborative effort, 30 percent of the BRE12-158 study participants were Black—a number that is significantly higher than the national average of 5 percent participation from Black patients in clinical trials, Bales noted.

Collaboration 52

Collaboration Sample 52